{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:46:41Z","timestamp":1782366401625,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05230-x","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:57:55Z","timestamp":1782363475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subgroup analysis of patients with Kawasaki Disease based on blood tests and cytokine profiles"],"prefix":"10.1038","author":[{"given":"Hiroshi","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Ansai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5230_CR1","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1111\/ped.70007","volume":"67","author":"Y Nakamura","year":"2025","unstructured":"Nakamura, Y., Yashiro, M. & Yanagawa, H. Epidemiology of Kawasaki disease in Japan in 2021-2022: results of the 27th nationwide survey. Pediatr. Int. 67, e70007 (2025).","journal-title":"Pediatr. Int."},{"key":"5230_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/1744666X.2015.1044980","volume":"11","author":"JC Burns","year":"2015","unstructured":"Burns, J. C. & Franco, A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev. Clin. Immunol. 11, 819\u2013825 (2015).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"5230_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/BF02073890","volume":"151","author":"S Furukawa","year":"1992","unstructured":"Furukawa, S. et al. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur. J. Pediatr. 151, 44\u201347 (1992).","journal-title":"Eur. J. Pediatr."},{"key":"5230_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","volume":"162","author":"S Jia","year":"2010","unstructured":"Jia, S., Li, C., Wang, G., Yang, J. & Zu, Y. The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin. Exp. Immunol. 162, 131\u2013137 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"5230_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cct.2016.04.002","volume":"48","author":"AH Tremoulet","year":"2016","unstructured":"Tremoulet, A. H. et al. Rationale and study design for a phase I\/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). Contemp. Clin. Trials 48, 70\u201375 (2016).","journal-title":"Contemp. Clin. Trials"},{"key":"5230_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00431-002-1018-5","volume":"161","author":"K Samada","year":"2002","unstructured":"Samada, K., Igarashi, H., Shiraishi, H., Hatake, K. & Momoi, M. Y. Increased serum granulocyte colony-stimulating factor correlates with coronary artery dilatation in Kawasaki disease. Eur. J. Pediatr. 161, 538\u2013541 (2002).","journal-title":"Eur. J. Pediatr."},{"key":"5230_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1046\/j.1442-200x.1999.01085.x","volume":"41","author":"S Kamizono","year":"1999","unstructured":"Kamizono, S., Yamada, A., Higuchi, T., Kato, H. & Itoh, K. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease. Pediatr. Int. 41, 341\u2013345 (1999).","journal-title":"Pediatr. Int."},{"key":"5230_CR8","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.111.072769","volume":"125","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation 125, 1542\u20131550 (2012).","journal-title":"Circulation"},{"key":"5230_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF01956740","volume":"152","author":"CY Lin","year":"1993","unstructured":"Lin, C. Y., Lin, C. C., Hwang, B. & Chiang, B. N. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur. J. Pediatr. 152, 309\u2013312 (1993).","journal-title":"Eur. J. Pediatr."},{"key":"5230_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1365-2249.2000.01395.x","volume":"122","author":"T Asano","year":"2000","unstructured":"Asano, T. & Ogawa, S. Expression of IL-8 in Kawasaki disease. Clin. Exp. Immunol. 122, 514\u2013519 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"5230_CR11","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2147\/JIR.S506154","volume":"18","author":"X Tu","year":"2025","unstructured":"Tu, X. et al. Serum Olink targeted proteomics identifies IL-17A as a prospective inflammatory marker for the prediction and diagnosis of Kawasaki disease. J. Inflamm. Res. 18, 3093\u20133103 (2025).","journal-title":"J. Inflamm. Res."},{"key":"5230_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-2478(98)00016-9","volume":"62","author":"GW Noh","year":"1998","unstructured":"Noh, G. W., Lee, W. G., Lee, W. & Lee, K. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease. Immunol. Lett. 62, 19\u201324 (1998).","journal-title":"Immunol. Lett."},{"key":"5230_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","volume":"47","author":"M Ayusawa","year":"2005","unstructured":"Ayusawa, M. et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr. Int. 47, 232\u2013234 (2005).","journal-title":"Pediatr. Int."},{"key":"5230_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.echo.2016.03.017","volume":"29","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi, T. et al. A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J. Am. Soc. Echocardiogr. 29, 794\u2013801 (2016).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"5230_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock, G. B., Schwartz, G. J. & Wisotsky, D. H. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J. Pediatr. 93, 62\u201366 (1978).","journal-title":"J. Pediatr."},{"key":"5230_CR16","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi, T. et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113, 2606\u20132612 (2006).","journal-title":"Circulation"},{"key":"5230_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00431-021-03966-8","volume":"180","author":"JH Park","year":"2021","unstructured":"Park, J. H. & Choi, H. J. Clinical implications of thrombocytosis in acute phase Kawasaki disease. Eur. J. Pediatr. 180, 1841\u20131846 (2021).","journal-title":"Eur. J. Pediatr."},{"key":"5230_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6421543","volume":"2022","author":"S Sarejloo","year":"2022","unstructured":"Sarejloo, S. et al. Neutrophil to lymphocyte ratio as a biomarker for predicting the coronary artery abnormality in Kawasaki disease: a meta-analysis. Dis. Markers 2022, 6421543 (2022).","journal-title":"Dis. Markers"},{"key":"5230_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00246-016-1525-1","volume":"38","author":"M Yamashita","year":"2017","unstructured":"Yamashita, M. et al. Difference in risk factors for subtypes of acute cardiac lesions resulting from Kawasaki disease. Pediatr. Cardiol. 38, 375\u2013380 (2017).","journal-title":"Pediatr. Cardiol."},{"key":"5230_CR20","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00431-024-05437-2","volume":"183","author":"L Wang","year":"2024","unstructured":"Wang, L., He, M., Wang, W., Li, S. & Zhao, G. Efficacy and safety of infliximab in the treatment of Kawasaki disease: a systematic review and meta-analysis. Eur. J. Pediatr. 183, 1765\u20131776 (2024).","journal-title":"Eur. J. Pediatr."},{"key":"5230_CR21","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"5230_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jlb.65.5.566","volume":"65","author":"M Terai","year":"1999","unstructured":"Terai, M. et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J. Leukoc. Biol. 65, 566\u2013572 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"5230_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1046\/j.1365-3083.2000.00650.x","volume":"51","author":"T Asano","year":"2000","unstructured":"Asano, T. & Ogawa, S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand. J. Immunol. 51, 98\u2013103 (2000).","journal-title":"Scand. J. Immunol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05230-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:57:56Z","timestamp":1782363476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":23,"alternative-id":["5230"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05230-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from the parents or guardians of all participants. The study protocol included an opt-out procedure for retrospective data analysis, which was approved by the institutional ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}